Surveillance strategies for individuals with identified CDH1 mutations typically involve regular upper gastrointestinal endoscopies (EGD) starting at an early age, although the efficacy of such surveillance remains debated due to the often normal findings in patients who later develop cancer [43]. This evidence concerns the gene CDH1 and cancer.